World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
44
Citations
15949
World Ranking
4740
National Ranking
2133

Overview

Srinivas S. Rao is affiliated with the National Institute of Allergy and Infectious Diseases in the United States. This association places them within a prominent research environment focused on advancing knowledge in immunology and infectious diseases.

Details on recent research papers, frequent co-authors, publication venues, specific fields of study, and topics of research for Srinivas S. Rao are not available, which limits a deeper insight into the scientist's academic output and collaboration network.

There are no records of book publications or awards attributed to this researcher at this time.

Their involvement with the National Institute of Allergy and Infectious Diseases suggests a professional focus on biomedical research, particularly in areas related to immune system function and infectious disease mechanisms, although no specific subfields or topics have been documented.

Best Publications

  • Microbial translocation is a cause of systemic immune activation in chronic HIV infection

    Jason M. Brenchley;David A. Price;Timothy W. Schacker;Tedi E. Asher

  • Structure-Based Design of a Fusion Glycoprotein Vaccine for Respiratory Syncytial Virus

    Jason S. McLellan;Man Chen;M. Gordon Joyce;Mallika Sastry

  • Self-assembling influenza nanoparticle vaccines elicit broadly neutralizing H1N1 antibodies

    Masaru Kanekiyo;Chih Jen Wei;Hadi M. Yassine;Patrick M. McTamney;Patrick M. McTamney

  • Hemagglutinin-stem nanoparticles generate heterosubtypic influenza protection

    Hadi M. Yassine;Jeffrey C. Boyington;Patrick M. McTamney;Patrick M. McTamney;Chih Jen Wei;Chih Jen Wei

  • A virus-like particle vaccine for epidemic Chikungunya virus protects nonhuman primates against infection

    Wataru Akahata;Zhi Yong Yang;Hanne Andersen;Siyang Sun

  • Induction of broadly neutralizing H1N1 influenza antibodies by vaccination

    Chih Jen Wei;Jeffrey C. Boyington;Patrick M. McTamney;Wing Pui Kong

  • Preserved CD4+ central memory T cells and survival in vaccinated SIV-challenged monkeys.

    Norman L. Letvin;John R. Mascola;Yue Sun;Darci A. Gorgone

  • Type I interferon responses in rhesus macaques prevent SIV infection and slow disease progression

    Netanya G. Sandler;Netanya G. Sandler;Steven E. Bosinger;Jacob D. Estes;Richard T R Zhu

  • Enhanced neonatal Fc receptor function improves protection against primate SHIV infection

    Sung Youl Ko;Amarendra Pegu;Rebecca S. Rudicell;Zhi Yong Yang

  • Protection against malaria at 1 year and immune correlates following PfSPZ vaccination.

    Andrew S Ishizuka;Kirsten E Lyke;Adam DeZure;Andrea A Berry

  • Rational Design of an Epstein-Barr Virus Vaccine Targeting the Receptor-Binding Site

    Masaru Kanekiyo;Wei Bu;M. Gordon Joyce;Geng Meng

  • CD4 T follicular helper cell dynamics during SIV infection

    Constantinos Petrovas;Takuya Yamamoto;Michael Y. Gerner;Kristin L. Boswell

  • Evaluation of candidate vaccine approaches for MERS-CoV

    Lingshu Wang;Wei Shi;M. Gordon Joyce;Kayvon Modjarrad

  • Enhanced Potency of a Broadly Neutralizing HIV-1 Antibody In Vitro Improves Protection against Lentiviral Infection In Vivo

    Rebecca S. Rudicell;Young Do Kwon;Sung-Youl Ko;Amarendra Pegu

  • Prospects for a safe COVID-19 vaccine.

    Barton F. Haynes;Lawrence Corey;Prabhavathi Fernandes;Peter B. Gilbert

  • CD8+ cellular immunity mediates rAd5 vaccine protection against Ebola virus infection of nonhuman primates

    Nancy J Sullivan;Lisa Hensley;Clement Asiedu;Thomas W Geisbert

  • Neutralizing antibodies to HIV-1 envelope protect more effectively in vivo than those to the CD4 receptor

    Amarendra Pegu;Zhi Yong Yang;Jeffrey C. Boyington;Lan Wu

  • Trispecific antibodies enhance the therapeutic efficacy of tumor-directed T cells through T cell receptor co-stimulation

    Lan Wu;Edward Seung;Ling Xu;Ercole Rao

  • Toward a live microbial microbicide for HIV: commensal bacteria secreting an HIV fusion inhibitor peptide.

    Srinivas Rao;Stella Hu;Louise McHugh;Kira Lueders

  • Immune and Genetic Correlates of Vaccine Protection Against Mucosal Infection by SIV in Monkeys

    Norman L. Letvin;Srinivas S. Rao;David C. Montefiori;Michael S. Seaman

  • Engineered Vaginal Lactobacillus Strain for Mucosal Delivery of the Human Immunodeficiency Virus Inhibitor Cyanovirin-N

    Xiaowen Liu;Laurel A. Lagenaur;David A. Simpson;Kirsten P. Essenmacher

Frequent Co-Authors

Gary J. Nabel
Gary J. Nabel ModeX Therapeutics
Norman L. Letvin
Norman L. Letvin Beth Israel Deaconess Medical Center
John R. Mascola
John R. Mascola ModeX Therapeutics
Mario Roederer
Mario Roederer National Institute of Allergy and Infectious Diseases
Zhi-Yong Yang
Zhi-Yong Yang Sanofi (United States)
Martha C. Nason
Martha C. Nason National Institutes of Health
Richard A. Koup
Richard A. Koup National Institute of Allergy and Infectious Diseases
Bette T. Korber
Bette T. Korber Los Alamos National Laboratory
Robert A. Seder
Robert A. Seder National Institute of Allergy and Infectious Diseases
Stephen D. Schmidt
Stephen D. Schmidt National Institutes of Health

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, branching out into related healthcare fields can provide diverse career options. Many students begin their journey with nursing degrees, and there are specialized options tailored for different backgrounds. For example, individuals without a nursing background may find online BSN programs for non nurses a convenient and flexible entry point into healthcare.

If you're looking for a shortcut to advance your nursing credentials, exploring the easiest ABSN to get into might be beneficial. These accelerated programs help students earn their Bachelor of Science in Nursing faster, which can open doors to clinical research or immunology nursing roles.

For those considering foundational nursing licenses, especially with less stringent entry criteria, LPN programs with easiest admission requirements provide an accessible path. Licensed Practical Nurses often work directly with immune-compromised patients, making this a relevant stepping stone.

Finally, for advancing to specialized clinical roles, easiest FNP program options allow nurses to become Family Nurse Practitioners faster, broadening their ability to engage in patient care that intersects with immunological health.

Best Scientists Citing Srinivas S. Rao

Trending Scientists